244 related articles for article (PubMed ID: 23043479)
1. The potentiality of vanadium in medicinal applications.
Rehder D
Future Med Chem; 2012 Sep; 4(14):1823-37. PubMed ID: 23043479
[TBL] [Abstract][Full Text] [Related]
2. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
[TBL] [Abstract][Full Text] [Related]
3. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis.
Mehdi MZ; Srivastava AK
Arch Biochem Biophys; 2005 Aug; 440(2):158-64. PubMed ID: 16055077
[TBL] [Abstract][Full Text] [Related]
4. Vanadium in diabetes: 100 years from Phase 0 to Phase I.
Thompson KH; Orvig C
J Inorg Biochem; 2006 Dec; 100(12):1925-35. PubMed ID: 17055061
[TBL] [Abstract][Full Text] [Related]
5. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
Srivastava AK; Mehdi MZ
Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
[TBL] [Abstract][Full Text] [Related]
6. Perspectives for vanadium in health issues.
Rehder D
Future Med Chem; 2016; 8(3):325-38. PubMed ID: 26898507
[TBL] [Abstract][Full Text] [Related]
7. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.
Saatchi K; Thompson KH; Patrick BO; Pink M; Yuen VG; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2689-97. PubMed ID: 15819554
[TBL] [Abstract][Full Text] [Related]
8. Vanadium. Its role for humans.
Rehder D
Met Ions Life Sci; 2013; 13():139-69. PubMed ID: 24470091
[TBL] [Abstract][Full Text] [Related]
9. Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review.
Scior T; Guevara-García A; Bernard P; Do QT; Domeyer D; Laufer S
Mini Rev Med Chem; 2005 Nov; 5(11):995-1008. PubMed ID: 16307529
[TBL] [Abstract][Full Text] [Related]
10. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Willsky GR; Goldfine AB; Kostyniak PJ; McNeill JH; Yang LQ; Khan HR; Crans DC
J Inorg Biochem; 2001 May; 85(1):33-42. PubMed ID: 11377693
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
12. Vanadium Compounds as PTP Inhibitors.
Irving E; Stoker AW
Molecules; 2017 Dec; 22(12):. PubMed ID: 29257048
[TBL] [Abstract][Full Text] [Related]
13. [Insulin-mimetic property of vanadium compounds].
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Postepy Biochem; 2016; 62(1):60-65. PubMed ID: 28132446
[TBL] [Abstract][Full Text] [Related]
14. [The vanadium compounds: chemistry, synthesis, insulinomimetic properties].
Fedorova EV; Buriakina AV; Vorob'eva NM; Baranova NI
Biomed Khim; 2014; 60(4):416-29. PubMed ID: 25249525
[TBL] [Abstract][Full Text] [Related]
15. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
Nakai M; Watanabe H; Fujiwara C; Kakegawa H; Satoh T; Takada J; Matsushita R; Sakurai H
Biol Pharm Bull; 1995 May; 18(5):719-25. PubMed ID: 7492989
[TBL] [Abstract][Full Text] [Related]
16. Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.
Treviño S; Díaz A; Sánchez-Lara E; Sanchez-Gaytan BL; Perez-Aguilar JM; González-Vergara E
Biol Trace Elem Res; 2019 Mar; 188(1):68-98. PubMed ID: 30350272
[TBL] [Abstract][Full Text] [Related]
17. The future of/for vanadium.
Rehder D
Dalton Trans; 2013 Sep; 42(33):11749-61. PubMed ID: 23567506
[TBL] [Abstract][Full Text] [Related]
18. Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds.
Crans DC
J Inorg Biochem; 2000 May; 80(1-2):123-31. PubMed ID: 10885472
[TBL] [Abstract][Full Text] [Related]
19. Potential use of vanadium compounds in therapeutics.
Barrio DA; Etcheverry SB
Curr Med Chem; 2010; 17(31):3632-42. PubMed ID: 20846114
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of vanadium(IV,V) hydroxamic acid complexes and in vivo assessment of their insulin-like activity.
Haratake M; Fukunaga M; Ono M; Nakayama M
J Biol Inorg Chem; 2005 May; 10(3):250-8. PubMed ID: 15806386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
